United States Biotechnology & Medical Research

Albany Molecular Research Inc (AMRI)

Track

Ticker: AMRI Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
MADDALUNA ANTHONY J Non-Executive Director
Transaction date
Purchase
Price
297.79
Quantity 67,598 +32.7%
Value US$4,811,275
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
156.25
Quantity 51,317 -8.5%
Value US$2,953,710
HENDERSON LORI M. SVP, Secretary & Gen Counsel Officer
Transaction date
Sale
Price
137.49
Quantity 22,580 -10.8%
Value US$3,987,744
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
16.79
Quantity 785 -2.2%
Value US$13,180
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
15.29
Quantity 1,401 -3.7%
Value US$21,421
OCONNOR KEVIN Non-Executive Director
Transaction date
Sale
Price
14.41
Quantity 5,000 -9.4%
Value US$72,050
Marth William S President and CEO Executive Director
Transaction date
Purchase
Price
12.86
Quantity 12,500 +2.4%
Value US$160,750
Svokos George Chief Operating Officer Officer
Transaction date
Purchase
Price
12.82
Quantity 12,500 +13.0%
Value US$160,250
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
12.77
Quantity 2,361 -5.9%
Value US$30,150
D AMBRA CONSTANCE M Large shareholder
Transaction date
Sale
Price
19.60
Quantity 50,000 -2.1%
Value US$980,000
D AMBRA THOMAS E Chairman, Board of Directors Non-Executive Director
Transaction date
Sale
Price
19.60
Quantity 50,000 -2.0%
Value US$980,000
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
20.45
Quantity 1,000 -3.4%
Value US$20,450
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
21.06
Quantity 5,000 -14.8%
Value US$105,300
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
19.99
Quantity 5,000 -14.8%
Value US$99,950
Marth William S President and CEO Executive Director
Transaction date
Purchase
Price
19.98
Quantity 10,000 +2.3%
Value US$199,800
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
19.58
Quantity 787 -2.7%
Value US$15,409
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
19.39
Quantity 3,750 -11.3%
Value US$72,712
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
19.20
Quantity 7,500 -19.4%
Value US$144,000
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
19.35
Quantity 7,000 -18.3%
Value US$135,450
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
18.53
Quantity 3,500 -11.2%
Value US$64,855
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
18.79
Quantity 441 -1.4%
Value US$8,286
OCONNOR KEVIN Non-Executive Director
Transaction date
Sale
Price
18.22
Quantity 5,000 -10.4%
Value US$91,100
ROTH ARTHUR J Non-Executive Director
Transaction date
Sale
Price
18.26
Quantity 5,000 -11.2%
Value US$91,300
Hagen Steven R SVP Manufacturing & Pharmaceut Officer
Transaction date
Sale
Price
18.30
Quantity 721 -2.2%
Value US$13,194
Svokos George Chief Commercial Officer Officer
Transaction date
Purchase
Price
17.72
Quantity 10,000 +16.5%
Value US$177,200
Marth William S President and CEO Executive Director
Transaction date
Purchase
Price
17.70
Quantity 20,000 +5.1%
Value US$354,000
Nolan Michael M CFO Officer
Transaction date
Sale
Price
16.17
Quantity 5,000 -6.8%
Value US$80,850
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
16.22
Quantity 3,750 -13.0%
Value US$60,825
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
16.46
Quantity 1,250 -4.7%
Value US$20,575
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
16.60
Quantity 3,750 -13.0%
Value US$62,250
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
16.48
Quantity 1,623 -6.1%
Value US$26,747
CABLE STUART M Large shareholder
Transaction date
Planned sale
Price
16.00
Quantity 10,391 -0.3%
Value US$166,262
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
16.06
Quantity 10,500 -25.3%
Value US$168,630
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
17.03
Quantity 7,500 -19.5%
Value US$127,725
Marth William S President and CEO Executive Director
Transaction date
Purchase
Price
17.01
Quantity 30,000 +9.6%
Value US$510,300
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
19.74
Quantity 1,250 -3.9%
Value US$24,675
Nolan Michael M SVP, CFO and Treasurer Officer
Transaction date
Sale
Price
19.76
Quantity 10,000 -11.6%
Value US$197,600
HENDERSON LORI M SVP, Secretary & Gen. Counsel Officer
Transaction date
Sale
Price
19.05
Quantity 30,000 -40.2%
Value US$571,500
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
18.99
Quantity 10,000 -24.4%
Value US$189,900
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
18.99
Quantity 797 -2.5%
Value US$15,135
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
16.93
Quantity 2,500 -7.3%
Value US$42,325
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
15.45
Quantity 1,250 -3.6%
Value US$19,312
Svokos George SVP Sales & GM of API Officer
Transaction date
Purchase
Price
15.60
Quantity 10,000 +22.4%
Value US$156,000
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
15.27
Quantity 2,500 -7.0%
Value US$38,175
Marth William S President and CEO Executive Director
Transaction date
Purchase
Price
15.40
Quantity 30,000 +10.6%
Value US$462,000
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
14.80
Quantity 2,500 -7.0%
Value US$37,000
Hagen Steven R SVP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
14.80
Quantity 897 -2.6%
Value US$13,276
ROTH ARTHUR J Non-Executive Director
Transaction date
Sale
Price
15.95
Quantity 5,000 -11.9%
Value US$79,750
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
15.73
Quantity 3,000 -7.9%
Value US$47,190
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
15.19
Quantity 2,500 -6.7%
Value US$37,975
Nolan Michael M VP, CFO and Treasurer Officer
Transaction date
Sale
Price
15.00
Quantity 15,000 -16.5%
Value US$225,000
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
14.87
Quantity 1,500 -4.1%
Value US$22,305
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
13.37
Quantity 1,500 -4.0%
Value US$20,055
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
10.93
Quantity 2,500 -8.4%
Value US$27,325
Marth William S Non-Executive Director
Transaction date
Purchase
Price
10.75
Quantity 30,000 +49.1%
Value US$322,500
Marth William S Non-Executive Director
Transaction date
Purchase
Price
11.57
Quantity 20,000 +48.6%
Value US$231,400
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
11.55
Quantity 2,300 -7.7%
Value US$26,565
Marth William S Non-Executive Director
Transaction date
Purchase
Price
10.23
Quantity 10,000 +35.3%
Value US$102,300
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
11.26
Quantity 800 -2.5%
Value US$9,008
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
10.97
Quantity 7,500 -11.6%
Value US$82,275
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
10.40
Quantity 1,200 -3.6%
Value US$12,480
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
9.91
Quantity 258 -0.4%
Value US$2,557
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
9.91
Quantity 180 -0.5%
Value US$1,784
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
9.98
Quantity 256 -0.4%
Value US$2,555
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
9.98
Quantity 249 -0.7%
Value US$2,485
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
10.69
Quantity 852 -1.5%
Value US$9,108
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
10.75
Quantity 677 -1.9%
Value US$7,278
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
10.75
Quantity 694 -1.2%
Value US$7,460
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
10.73
Quantity 1,070 -1.8%
Value US$11,481
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
10.25
Quantity 3,538 -5.5%
Value US$36,264
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
9.56
Quantity 1,000 -2.8%
Value US$9,560
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
8.18
Quantity 984 -2.7%
Value US$8,049
Sargent Bruce J Sr VP, Drug Discovery Officer
Transaction date
Sale
Price
8.18
Quantity 984 -1.5%
Value US$8,049
Hagen Steven R Sr VP Pharmaceutical Dev & Mfg Officer
Transaction date
Sale
Price
7.89
Quantity 1,000 -2.6%
Value US$7,890
Marth William S Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 10,000 +80.3%
Value US$50,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-12-05 2016-12-02 B Purchase MADDALUNA ANTHONY J Non-Executive Director
67,598 +32.7%
297.79
US$4,811,275 		67,598 +32.7% 297.79 US$4,811,275
2016-12-01 2016-11-30 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
51,317 -8.5%
156.25
US$2,953,710 		51,317 -8.5% 156.25 US$2,953,710
2016-11-17 2016-11-16 S Sale HENDERSON LORI M.

SVP, Secretary & Gen Counsel

Officer
22,580 -10.8%
137.49
US$3,987,744 		22,580 -10.8% 137.49 US$3,987,744
2016-11-10 2016-11-10 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
785 -2.2%
16.79
US$13,180 		785 -2.2% 16.79 US$13,180
2016-08-10 2016-08-09 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
1,401 -3.7%
15.29
US$21,421 		1,401 -3.7% 15.29 US$21,421
2016-06-01 2016-05-31 S Sale OCONNOR KEVIN Non-Executive Director
5,000 -9.4%
14.41
US$72,050 		5,000 -9.4% 14.41 US$72,050
2016-05-16 2016-05-16 B Purchase Marth William S

President and CEO

Executive Director
12,500 +2.4%
12.86
US$160,750 		12,500 +2.4% 12.86 US$160,750
2016-05-16 2016-05-13 B Purchase Svokos George

Chief Operating Officer

Officer
12,500 +13.0%
12.82
US$160,250 		12,500 +13.0% 12.82 US$160,250
2016-05-16 2016-05-13 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
2,361 -5.9%
12.77
US$30,150 		2,361 -5.9% 12.77 US$30,150
2015-11-10 2015-11-09 S Sale D AMBRA CONSTANCE M Large shareholder
50,000 -2.1%
19.60
US$980,000 		50,000 -2.1% 19.60 US$980,000
2015-11-10 2015-11-09 S Sale D AMBRA THOMAS E

Chairman, Board of Directors

Non-Executive Director
50,000 -2.0%
19.60
US$980,000 		50,000 -2.0% 19.60 US$980,000
2015-08-17 2015-08-17 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
1,000 -3.4%
20.45
US$20,450 		1,000 -3.4% 20.45 US$20,450
2015-08-10 2015-08-07 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
5,000 -14.8%
21.06
US$105,300 		5,000 -14.8% 21.06 US$105,300
2015-06-09 2015-06-08 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
5,000 -14.8%
19.99
US$99,950 		5,000 -14.8% 19.99 US$99,950
2015-06-08 2015-06-04 B Purchase Marth William S

President and CEO

Executive Director
10,000 +2.3%
19.98
US$199,800 		10,000 +2.3% 19.98 US$199,800
2015-06-05 2015-06-04 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
787 -2.7%
19.58
US$15,409 		787 -2.7% 19.58 US$15,409
2015-06-04 2015-06-02 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
3,750 -11.3%
19.39
US$72,712 		3,750 -11.3% 19.39 US$72,712
2015-05-11 2015-05-08 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
7,500 -19.4%
19.20
US$144,000 		7,500 -19.4% 19.20 US$144,000
2015-05-11 2015-05-08 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
7,000 -18.3%
19.35
US$135,450 		7,000 -18.3% 19.35 US$135,450
2015-03-19 2015-03-17 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
3,500 -11.2%
18.53
US$64,855 		3,500 -11.2% 18.53 US$64,855
2015-03-16 2015-03-13 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
441 -1.4%
18.79
US$8,286 		441 -1.4% 18.79 US$8,286
2015-03-13 2015-03-12 S Sale OCONNOR KEVIN Non-Executive Director
5,000 -10.4%
18.22
US$91,100 		5,000 -10.4% 18.22 US$91,100
2015-03-13 2015-03-12 S Sale ROTH ARTHUR J Non-Executive Director
5,000 -11.2%
18.26
US$91,300 		5,000 -11.2% 18.26 US$91,300
2015-03-12 2015-03-11 S Sale Hagen Steven R

SVP Manufacturing & Pharmaceut

Officer
721 -2.2%
18.30
US$13,194 		721 -2.2% 18.30 US$13,194
2015-03-11 2015-03-10 B Purchase Svokos George

Chief Commercial Officer

Officer
10,000 +16.5%
17.72
US$177,200 		10,000 +16.5% 17.72 US$177,200
2015-03-06 2015-03-05 B Purchase Marth William S

President and CEO

Executive Director
20,000 +5.1%
17.70
US$354,000 		20,000 +5.1% 17.70 US$354,000
2015-02-27 2015-02-25 S Sale Nolan Michael M

CFO

Officer
5,000 -6.8%
16.17
US$80,850 		5,000 -6.8% 16.17 US$80,850
2015-02-25 2015-02-23 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
3,750 -13.0%
16.22
US$60,825 		3,750 -13.0% 16.22 US$60,825
2015-02-20 2015-02-18 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,250 -4.7%
16.46
US$20,575 		1,250 -4.7% 16.46 US$20,575
2015-02-20 2015-02-18 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
3,750 -13.0%
16.60
US$62,250 		3,750 -13.0% 16.60 US$62,250
2015-02-20 2015-02-18 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,623 -6.1%
16.48
US$26,747 		1,623 -6.1% 16.48 US$26,747
2014-12-05 2014-12-04 PlS Planned sale CABLE STUART M Large shareholder
10,391 -0.3%
16.00
US$166,262 		10,391 -0.3% 16.00 US$166,262
2014-11-18 2014-11-14 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
10,500 -25.3%
16.06
US$168,630 		10,500 -25.3% 16.06 US$168,630
2014-11-12 2014-11-10 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
7,500 -19.5%
17.03
US$127,725 		7,500 -19.5% 17.03 US$127,725
2014-11-10 2014-11-10 B Purchase Marth William S

President and CEO

Executive Director
30,000 +9.6%
17.01
US$510,300 		30,000 +9.6% 17.01 US$510,300
2014-09-02 2014-08-28 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,250 -3.9%
19.74
US$24,675 		1,250 -3.9% 19.74 US$24,675
2014-08-14 2014-08-14 S Sale Nolan Michael M

SVP, CFO and Treasurer

Officer
10,000 -11.6%
19.76
US$197,600 		10,000 -11.6% 19.76 US$197,600
2014-08-13 2014-08-12 S Sale HENDERSON LORI M

SVP, Secretary & Gen. Counsel

Officer
30,000 -40.2%
19.05
US$571,500 		30,000 -40.2% 19.05 US$571,500
2014-08-12 2014-08-08 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
10,000 -24.4%
18.99
US$189,900 		10,000 -24.4% 18.99 US$189,900
2014-08-12 2014-08-08 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
797 -2.5%
18.99
US$15,135 		797 -2.5% 18.99 US$15,135
2014-06-04 2014-06-03 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
2,500 -7.3%
16.93
US$42,325 		2,500 -7.3% 16.93 US$42,325
2014-05-20 2014-05-16 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
1,250 -3.6%
15.45
US$19,312 		1,250 -3.6% 15.45 US$19,312
2014-05-16 2014-05-15 B Purchase Svokos George

SVP Sales & GM of API

Officer
10,000 +22.4%
15.60
US$156,000 		10,000 +22.4% 15.60 US$156,000
2014-05-13 2014-05-12 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
2,500 -7.0%
15.27
US$38,175 		2,500 -7.0% 15.27 US$38,175
2014-05-13 2014-05-12 B Purchase Marth William S

President and CEO

Executive Director
30,000 +10.6%
15.40
US$462,000 		30,000 +10.6% 15.40 US$462,000
2014-05-13 2014-05-09 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
2,500 -7.0%
14.80
US$37,000 		2,500 -7.0% 14.80 US$37,000
2014-05-13 2014-05-09 S Sale Hagen Steven R

SVP Pharmaceutical Dev & Mfg

Officer
897 -2.6%
14.80
US$13,276 		897 -2.6% 14.80 US$13,276
2014-02-28 2014-02-27 S Sale ROTH ARTHUR J Non-Executive Director
5,000 -11.9%
15.95
US$79,750 		5,000 -11.9% 15.95 US$79,750
2014-02-27 2014-02-27 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
3,000 -7.9%
15.73
US$47,190 		3,000 -7.9% 15.73 US$47,190
2014-02-25 2014-02-25 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
2,500 -6.7%
15.19
US$37,975 		2,500 -6.7% 15.19 US$37,975
2014-02-25 2014-02-24 S Sale Nolan Michael M

VP, CFO and Treasurer

Officer
15,000 -16.5%
15.00
US$225,000 		15,000 -16.5% 15.00 US$225,000
2014-02-24 2014-02-21 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,500 -4.1%
14.87
US$22,305 		1,500 -4.1% 14.87 US$22,305
2014-02-19 2014-02-19 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,500 -4.0%
13.37
US$20,055 		1,500 -4.0% 13.37 US$20,055
2013-12-04 2013-12-04 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
2,500 -8.4%
10.93
US$27,325 		2,500 -8.4% 10.93 US$27,325
2013-12-04 2013-12-03 B Purchase Marth William S Non-Executive Director
30,000 +49.1%
10.75
US$322,500 		30,000 +49.1% 10.75 US$322,500
2013-11-22 2013-11-22 B Purchase Marth William S Non-Executive Director
20,000 +48.6%
11.57
US$231,400 		20,000 +48.6% 11.57 US$231,400
2013-11-22 2013-11-22 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
2,300 -7.7%
11.55
US$26,565 		2,300 -7.7% 11.55 US$26,565
2013-06-04 2013-06-03 B Purchase Marth William S Non-Executive Director
10,000 +35.3%
10.23
US$102,300 		10,000 +35.3% 10.23 US$102,300
2013-05-31 2013-05-29 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
800 -2.5%
11.26
US$9,008 		800 -2.5% 11.26 US$9,008
2013-05-23 2013-05-22 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
7,500 -11.6%
10.97
US$82,275 		7,500 -11.6% 10.97 US$82,275
2013-05-13 2013-05-10 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,200 -3.6%
10.40
US$12,480 		1,200 -3.6% 10.40 US$12,480
2013-03-20 2013-03-19 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
258 -0.4%
9.91
US$2,557 		258 -0.4% 9.91 US$2,557
2013-03-20 2013-03-19 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
180 -0.5%
9.91
US$1,784 		180 -0.5% 9.91 US$1,784
2013-03-20 2013-03-18 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
256 -0.4%
9.98
US$2,555 		256 -0.4% 9.98 US$2,555
2013-03-20 2013-03-18 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
249 -0.7%
9.98
US$2,485 		249 -0.7% 9.98 US$2,485
2013-03-13 2013-03-13 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
852 -1.5%
10.69
US$9,108 		852 -1.5% 10.69 US$9,108
2013-03-14 2013-03-12 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
677 -1.9%
10.75
US$7,278 		677 -1.9% 10.75 US$7,278
2013-03-13 2013-03-12 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
694 -1.2%
10.75
US$7,460 		694 -1.2% 10.75 US$7,460
2013-03-13 2013-03-12 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
1,070 -1.8%
10.73
US$11,481 		1,070 -1.8% 10.73 US$11,481
2013-03-13 2013-03-11 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
3,538 -5.5%
10.25
US$36,264 		3,538 -5.5% 10.25 US$36,264
2013-03-11 2013-03-07 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,000 -2.8%
9.56
US$9,560 		1,000 -2.8% 9.56 US$9,560
2013-02-26 2013-02-22 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
984 -2.7%
8.18
US$8,049 		984 -2.7% 8.18 US$8,049
2013-02-26 2013-02-22 S Sale Sargent Bruce J

Sr VP, Drug Discovery

Officer
984 -1.5%
8.18
US$8,049 		984 -1.5% 8.18 US$8,049
2013-02-21 2013-02-19 S Sale Hagen Steven R

Sr VP Pharmaceutical Dev & Mfg

Officer
1,000 -2.6%
7.89
US$7,890 		1,000 -2.6% 7.89 US$7,890
2012-12-04 2012-12-03 B Purchase Marth William S Non-Executive Director
10,000 +80.3%
5.00
US$50,000 		10,000 +80.3% 5.00 US$50,000
Explore more

More insider trading research around Albany Molecular Research Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America